Data as of Sep 29, 2026 · Based on 200 AI responses · See how Parse measures this
Caris Life Sciences provides a precision oncology platform that analyzes DNA, RNA, and proteins from tumor tissue and blood to deliver comprehensive molecular profiling for cancer care. This platform combines multimodal data and AI-driven insights to inform diagnosis, guide treatment selection, enable early detection with Caris Detect, and monitor disease, connecting patients, physicians, and biopharma. Alongside diagnostic tests and services (tissue and blood labs, molecular tumor boards, and clinical trial matching), Caris supports drug development and commercialization through a large database of molecular and clinical outcomes.
1%<1% before. Up 1 point.
of AI answers about Caris Life Sciences and its rivals. Week of Sep 21
“Caris Life Sciences — Builds a comprehensive molecular profile using DNA, RNA and proteins”
“Caris Life Sciences — Combines molecular profiling with AI to match cancer patients to targeted therapies and immunotherapies.”
“Caris Life Sciences — launched an AI-powered multi-cancer detection blood test combining genomic and transcriptomic sequencing approaches.”
AI mentioned Caris Life Sciences in 1% of answers about Caris Life Sciences and its rivals in the week of Sep 21.
